Gerald D Natzke - Comment

Document ID: FDA-2011-N-0599-0009
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: February 15 2012, at 12:00 AM Eastern Standard Time
Date Posted: February 28 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: November 16 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: April 25 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80fb7b2c
View Document:

This is comment on Notice

Report of Scientific and Medical Literature and Information on Non-Standardized Allergenic Extracts, etc.: Center for Biologics Evaluation and Research; Extension of Comment Period

View Comment

To whom it may concern, We have provided safe and effective testing and treatment of allergies with these extracts the FDA is considering ending the production of. As harm from these extracts are negligable to non-existent and have provided an wonderful opportunity for patients to dramatically improve their health I must strongly request that they not be discontinued. Should it happen, it will be clearly understood that they were not removed from the market for the safety of the patient or the efficacy of the products they helped create. Sincerely, Gerald Natzke DO AAOA AAEM

Related Comments

View All

Total: 33

Roger James Simpson - Comment
Public Submission Posted: 11/23/2011 ID: FDA-2011-N-0599-0005